Project Grant 2449357

Award Date 8/1/25
Completion Date 7/31/26
Dollars Obligated $300K
Federal Grant Program
47.084
Assistance Type
Project Grant
Place of Performance
Los Angeles, CA 90089, USA
Similar Awards
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $274,976 to Ecate LLC aims to develop a novel intraspinal stimulator system to restore sensation and volitional motor control in spinal cord injury patients. The project will fabricate nanopatterned stimulating electrodes coupled with custom CMOS chips to deliver spatially selective electrical stimulation to the spinal cord. This closed-loop neural interface system is intended...
This Project Grant award from the National Science Foundation (NSF) under the Engineering program (CFDA 47.041) will provide $432,452 to New York University (NYU) from May 1, 2025 to April 30, 2030 to develop innovative wireless systems for high-resolution neural recording and brain-machine interface applications. The key objectives are to advance wireless power transmission, increase communication bandwidth, and scale up high-channel-count neural electrode arrays. This will involve creating...
This $600,000 Project Grant from the National Science Foundation's Division of Information and Intelligent Systems, under the Computer and Information Science and Engineering program (CFDA 47.070), will fund research at The Pennsylvania State University to develop a fully wireless, flexible electrical-acoustic implant for high-resolution neural stimulation and recording across large-scale brain circuits. The implant is intended to provide minimally invasive ultrasound neuromodulation and...
This National Science Foundation (NSF) Project Grant award, funded under the Engineering program (CFDA 47.041), aims to establish closed-loop hybrid intelligence (HI) by co-designing high-resolution neuromodulation and neuromorphic devices for application to cultured neurons and organoids. The key products and services to be delivered through this $200,000 award, with a performance period from June 15, 2025 to May 31, 2028, include: Developing optogenetic cell interfaces composed of close-packed...
This $1,227,590 project grant from the National Science Foundation's (NSF) Integrative Activities program (CFDA 47.083) supports the acquisition of a mobile, integrated behavior-brain-physiology capture system for studying human behavior and neurodevelopment. Led by Dr. Jessica Bradshaw and collaborators at the University of South Carolina and the Carolina Autism and Neurodevelopment Research Center, this multi-modal system synchronizes recordings of behavior, brain activity, autonomic function,...
This $260,609 Project Grant from the National Science Foundation Division of Electrical, Communications and Cyber Systems will support the development of multi-channel, sub-microliter implants for selective neuromodulation at Boise State University from September 1, 2023 through August 31, 2028. The grant is jointly funded through NSF's Engineering Directorate and Established Program to Stimulate Competitive Research, both of which aim to advance innovation in engineering research. Under this...
This Project Grant award, funded by the National Science Foundation's Engineering program (CFDA 47.041), supports the development of a novel non-surgical bioelectronic brain implant technology. The $599,918 award to the Massachusetts Institute of Technology (MIT) aims to create intravenously-introduced bioelectronic devices that can autonomously implant in target brain regions without the need for invasive surgery. The proposed technology promises to enable high-resolution brain stimulation...
Neurodyne, Inc. received a $275,648 National Science Foundation Project Grant under the NSF Technology, Innovation, and Partnerships program (CFDA 47.084) to develop an Analog Front End (AFE) platform for lightweight, long-term cortical monitoring. The grant period runs from February 15, 2021 through May 31, 2022. The NSF Technology, Innovation, and Partnerships program seeks to advance science and engineering research and innovation leading to breakthrough technologies as well as solutions to...
This Project Grant award from the National Science Foundation (NSF) Computer and Information Science and Engineering (CISE) program (CFDA 47.070) provides $283,596 to the University of California, Irvine to develop conformable, expandable neural interface devices that can monitor brain activity as animals transition to performing complex cognitive behaviors. The goal is to identify neurophysiological signatures of emerging cognition and improve understanding of how brain circuits form to support...
This $399,728 Project Grant award from the National Science Foundation's Engineering program (CFDA 47.041) supports the development of a new soft, biocompatible, and conformal 3D microelectronic system called "HotPocket" at the University of North Carolina at Chapel Hill. The goal is to create a technology that can longitudinally monitor and modulate the electrical and biochemical activity of brain organoids, which are lab-grown models that mimic parts of the human brain. This system...

This Project Grant award of $300,000 from the National Science Foundation (NSF) under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program supports the development and documentation of an open-source ecosystem for neuromodulation devices. The University of Southern California (USC) will engage with a community of physicians, researchers, and entrepreneurs to better understand the needs and opportunities in open-source neuromodulation technology. This will guide the establishment of a sustainable governance structure for the Center for Autonomic Recording and Stimulation Systems (CARSS), which has developed the OpenNERVE neuromodulation implant and compatible sensors/stimulators. The goal is to accelerate innovation in neuromodulation devices and expand access to life-changing therapies, especially for patients with rare diseases, by formalizing a collaborative community to advance these technologies into clinical use. The award period is from August 1, 2025 to July 31, 2026.

Generated 8/5/25, 2:46 AM